Gymboree 3rd-qtr sales at stores open a year or more drops 4 percent; raises profit outlookNovember 5th, 2009 Gymboree 3rd-qtr sales comparison falls 4 percentSAN FRANCISCO — The Gymboree Corp. on Thursday said its third-quarter sales at stores open at least a year fell 4 percent, but the children's retailer nevertheless raised its profit forecast for the period.
Watson Pharmaceuticals' 3rd-quarter profit falls 11 percent on higher taxes, chargesNovember 4th, 2009 Watson 3Q profit falls 11 percent on taxes, costsMORRISTOWN, N.J. — Drug developer Watson Pharmaceuticals Inc.
Valeant Pharmaceuticals' 3rd-qtr net income falls, but adjusted results top analyst forecastsNovember 2nd, 2009 Valeant 3Q net income down, results top forecastALISO VIEJO, Calif. — Valeant Pharmaceuticals International said Monday its third-quarter net income plunged, a year after selling businesses in Europe, Africa, and the Middle East, but adjusted profit topped Wall Street expectations.
OSI Pharmaceuticals' 3rd-quarter profit falls on costs, taxes, but revenue tops forecastsOctober 22nd, 2009 OSI Pharma 3rd-qtr profit falls on costs, taxesMELVILLE, N.Y. — Shares of drug developer OSI Pharmaceuticals Inc.
Cruise liner Carnival tops forecasts for 3Q despite 20 percent profit declineSeptember 22nd, 2009 Carnival profit falls 20 pct, still beats StreetCHICAGO — Carnival Corp. said Tuesday that its third-quarter profit fell nearly 20 percent, but the results were still better than expected as fuel prices fell and more travelers booked cruises.
Luxury retailer Tiffany's 2nd-qtr profit falls on lower sales, still beats analysts' estimatesAugust 28th, 2009 Tiffany 2Q profit falls, but tops viewNEW YORK — Tiffany & Co. says its second-quarter profit fell 30 percent as sales slipped, but the results beat analysts' estimates.
Analog Devices says 3rd-quarter profit falls by more than half, but still tops estimatesAugust 18th, 2009 Analog Devices 3Q profit falls 53 percentNORWOOD, Mass. — Chip designer Analog Devices Inc.
Fossil 2nd-quarter profit drops partly on recession, but results beat analysts' estimatesAugust 11th, 2009 Fossil 2Q profit falls, but tops Wall StreetRICHARDSON, Texas — Watchmaker Fossil Inc. said Tuesday that its second-quarter profit dropped 34 percent due to the ongoing economic downturn and stronger dollar, but the results managed to beat Wall Street's expectations.
King Pharmaceuticals says 2nd quarter profit falls, but performance tops expectationsAugust 6th, 2009 King Pharmaceuticals reports 2Q profit dropBRISTOL, Tenn. — Drug developer King Pharmaceuticals said Thursday its second-quarter profit dropped, as generic competition continued to hurt drug sales.
Ace Limited's 2nd-quarter profit, but adjusted result beats analysts' forecastJuly 27th, 2009 Ace Limited profit shrinks, but tops forecastBOSTON — Property and casualty insurer ACE Ltd. said Monday its second-quarter profit fell 28 percent on a decline in sales of insurance policies and reduced investment income.
Abbott Laboratories' 2nd-quarter profit falls 3 percent on mix of charges but meets forecastsJuly 15th, 2009 Abbott Laboratories 2Q profit falls 3 percentNORTH CHICAGO, Ill. — Drug developer and medical device maker Abbott Laboratories said Wednesday its second-quarter profit fell 3 percent on a mix of buyout and restructuring charges, but the results still met Wall Street forecasts.
MetroPCS tops 1Q profit forecast with growing customer base, but misses on salesMay 8th, 2009 MetroPCS 1Q profit rises, tops forecastDALLAS — Wireless carrier MetroPCS Communications Inc. said Thursday its first-quarter profit jumped 11 percent, helped by a growing subscriber base as it expanded into the New York City and Boston areas.
GlaxoSmithKline Pharmaceuticals net sales up 9.3 percentApril 28th, 2009 MUMBAI - GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended March 31. The Company has posted a net sales growth of 9.3 per cent compared to the previous quarter, while Profit Before Tax has grown by 7.9 percent, on a comparable basis.
German pharma, chemical company Merck sees 1st-quarter net profit drop 76 percentApril 27th, 2009 Merck 1Q net profit falls 76 percentFRANKFURT — German pharmaceutical and chemical company Merck KGaA said Monday that its first-quarter net profit dropped by 76 percent as demand for chemicals in particular declined. Darmstadt-based Merck said net profit for the January-March quarter fell to euro57 million ($75 million) from euro239 million a year earlier.
King Pharmaceuticals CEO Brian Markison's compensation falls by nearly half in 2008April 24th, 2009 King Pharma CEO's pay falls by nearly half in 2008NEW YORK — King Pharmaceuticals Inc. in 2008 paid its chief executive a little more than half his compensation from the previous year, largely because of a decline in stock and options awards, according to an Associated Press analysis of a regulatory filing.
Loading ...